Client News

VeonGen Announces FDA Alignment on Pivotal Phase 3 Development and Clinical Progress of VG801 for Stargardt Disease

Mallia Aesthetics and Neomed Enter Exclusive Middle East Partnership with First 8T3 Essentials Approval Granted

MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines

AFYREN and MINASOLVE announce partnership agreement to jointly develop key bio-based molecules for the fragrances industry at industrial scale

Topadur’s Phase 2a Trial of TOP-N53 for Systemic Sclerosis-Associated Digital Ulcers Advances to Next Dose Levels

QUANTRO Therapeutics secures key Austrian research grant to build its AI‑powered drug discovery platform

InflaRx Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day

Abivax to Participate in Upcoming Fall Investor Conferences

NVision Unveils First Manufacturable Molecular Qubit, Breakthrough Validated in Peer-Reviewed Nature Paper

DEBRA Research Invests in Topadur to Advance Small-Molecule Therapies for Dystrophic Epidermolysis Bullosa